Pretty normal Vetrun. Cash backing is around 4.5c and there has been a heavy block at 3.8-4.0 for a while, with high volatility, low volume trading between 4.1 and 4.7 for a while. Essentially any half decent sized trade has been moving it a few pips at a time.
The company has a 8 million loan at high interest to BYE (covering outgoings + approx 500k per annum additionalincome), along with a 10% interest in a future BYE well (Bivouac Peak). However, Bivouac Peak is on the backburner until BYE secure additional funding to get an offshore well into production. At this point I'm expecting the Bivouac Peak drilling to occur around Q4 2017/Q1 2018. MEL have stated that they are analysing other investment options, however we've had essentially a year of nothing. Hence why we are sitting around cash backing.
Essentially it is a trading play thing between 4.1 and 4.7 ish until we get some sort of news relating to a further investment opportunity or the Bivouac Peak well.
- Forums
- ASX - By Stock
- Mel position re:NSW acreage?
MEL
metgasco ltd
Add to My Watchlist
0.00%
!
0.2¢

Pretty normal Vetrun. Cash backing is around 4.5c and there has...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.665M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $2.284K | 1.142M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 19005694 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 11409690 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 19005694 | 0.002 |
7 | 34000999 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 6059665 | 11 |
0.004 | 10479052 | 6 |
0.006 | 311675 | 1 |
0.020 | 15085 | 1 |
0.022 | 91666 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MEL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online